NDC 58160-827-30

Menveo 10 ug/.5mL

Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine · INJECTION, SOLUTION

No Recall History

Menveo is a injection, solution containing meningococcal (groups a, c, y and w-135) oligosaccharide diphtheria crm197 conjugate vaccine at a strength of 10 ug/.5mL. Manufactured by GlaxoSmithKline Biologicals SA.

Key Facts

Brand Name: Menveo
Generic Name: Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine
NDC Code (Package): 58160-827-30
NDC Code (Product): 58160-827
Manufacturer: GlaxoSmithKline Biologicals SA
Strength: 10 ug/.5mL
Dosage Form: INJECTION, SOLUTION
Route: INTRAMUSCULAR
Marketing Status
Application #: BLA125300
Marketing Start: 12/09/2022

Recall History

No Recall History

View Full Drug Page

Menveo — All Packages

Not medical advice. This information is for reference only. Always consult your doctor or pharmacist.